These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16414136)

  • 1. Attempts to predict the long-term decrease in lung function due to radiotherapy of non-small cell lung cancer.
    Nielsen M; Hansen O; Vach W
    Radiother Oncol; 2006 Feb; 78(2):165-8. PubMed ID: 16414136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
    Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.
    Kyas I; Hof H; Debus J; Schlegel W; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.
    Jaén J; Vázquez G; Alonso E; León A; Guerrero R; Almansa JF
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1381-8. PubMed ID: 16757130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
    Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
    Henderson M; McGarry R; Yiannoutsos C; Fakiris A; Hoopes D; Williams M; Timmerman R
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):404-9. PubMed ID: 18394819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.
    Johnson M; Colonias A; Parda D; Trombetta M; Gayou O; Reitz B; Miften M
    Phys Med Biol; 2007 Mar; 52(5):1237-45. PubMed ID: 17301451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
    Hope AJ; Lindsay PE; El Naqa I; Alaly JR; Vicic M; Bradley JD; Deasy JO
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):112-24. PubMed ID: 16618575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
    Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
    Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.